Immunosuppression for clinical marrow transplantation.
D000741:Anemia, Aplastic / Q000628:therapy; D000818:Animals; D000961:Antilymphocyte Serum / Q000008:administration & dosage / Q000627:therapeutic use; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D009202:Cardiomyopathies / Q000139:chemically induced; D003037:Cobalt Radioisotopes; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006087:Graft vs Host Reaction; D000882:Haplorhini; D006689:Hodgkin Disease / Q000628:therapy; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007621:Karyotyping; D007948:Leukemia, Monocytic, Acute / Q000628:therapy; D015470:Leukemia, Myeloid, Acute / Q000628:therapy; D051379:Mice; D011828:Radiation Chimera; D014181:Transplantation Immunology; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D003037:Cobalt Radioisotopes; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide